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carbapenemase genes, polymerase chain reaction (PCR) assay was performed for detection of various carbapenemase genes bla VIM , bla NDM , bla IMP , bla , bla , -24/40 and -58 . [6] [7] [8] [9] Imipenem nonsusceptible carbapenemase negative isolates were screened for existence of OprD gene using OprD gene-specific primers (forward primer: CGGCGACATCAGCAACACC and reverse primer: GGGCCGTTGAAGTCGGAGTA). [5] The reaction condition was 2 min at 95°C; 34 cycles of 20 s at 95°C, 45 s at 60°C, 1 min at 72°C and finally, 3 min at 72°C. The amplified products were analysed by 1% (w/w) agarose gel electrophoresis and were visualised after staining with ethidium bromide. Mutation in the OprD gene was identified by denaturing gradient gel electrophoresis (DGGE). The products showing variations in DGGE were sequenced, analysed and compared with that of the reference strain P. aeruginosa PAO1 (GenBank accession no. CAA78448). Expression of OprD gene was determined by quantitative real-time PCR as described previously with some modification. [5] Reduced OprD expression was considered significant when it was ≤30% compared with that of P. aeruginosa PAO1. [5] REP PCR was performed to determine clonal relatedness of all the imipenem-nonsusceptible isolates. [10] Among 267 P. aeruginosa isolates, 63 were resistant and above breakpoint level for both imipenem and meropenem [ Table 1 ]. Among these 63 carbapenem-nonsusceptible isolates, carbapenemase activity was absent in 19 of them and multiplex PCR could not establish the presence of carbapenemase genes in the isolates. All the imipenem-resistant carbapenemase-nonproducing isolates were of multidrug-resistant phenotype and Polymixin B came up with moderate activity.
Visible amplification with targeted OprD region was observed in all the 19 carbapenem-nonsusceptible carbapenemase-nonproducing isolates, whereas variation in band pattern was noticed in 11 of them while performing DGGE with amplified products. All the 11 variable band patterns were further sequenced and compared with that of PAO1 to establish three patterns of mutation in three isolates (Pattern 1: PA594, Pattern 2: PA274 and Pattern 3: PA523). PA594 displayed a gap of 3 bp and point mutation of 14 bp. Protein sequence alignment of OprD porin (www.ncbi.nlm.nih. gov/BLAST) from PA594 with that of PAO1 rather revealed an interesting result. OprD porin of PA594 shared only 77% homology with that of PAO1. PA274 showed point mutation of 20 bp and 1 bp gap, whereas PA 523 exhibited a gap of 2 bp and point mutation of 21 bp. OprD protein sequences of PA 274 and PA 523 share 92% and 91% homology with that of PAO1, respectively. All the three isolates had a significant decrease in OprD expression (≤30%) in comparison to that of P. aeruginosa PAO1 [ Figure 1 ]. REP PCR revealed that all the test isolates were clonally nonrelated.
Carbapenems, such as imipenem and meropenem, are considered as the most effective therapeutic options in infections caused by multidrug-resistant P. aeruginosa. [11] Carbapenem resistance may emerge due to prolonged exposure and may involve various mechanisms. Various mechanisms are being reported for carbapenem resistance while majority of the studies focused on resistance due to the production of carbapenemases. Recently, Carba NP test is introduced which is a simple and rapid test to detect carbapenemase-mediated resistance. [12] Thus, there is a need to focus on intrinsic resistance mechanisms, especially porin alteration which also confers significant imipenem resistance. As very little data are available from this part of the country, so this study was undertaken to investigate the role of porin-based intrinsic mechanism in conferring carbapenem resistance.
Among 11 isolates with variable DGGE band patterns, inactivating mutations were found to be present in OprD gene of three isolates (PA594, PA274 and PA523) which were further confirmed by sequence analysis. Protein sequence alignment of the target region revealed variation in amino acids. Although amino acid changes are not related with expression of OprD, it might lead to loss of function of OprD which explains high MIC for these isolates. PA594 with only 77% homology with that of PAO1 exhibited MIC of 128 µg/mL for imipenem whereas PA274 and PA523 shared 91% and 92% homology, respectively, along with their MIC value being 64 µg/mL towards imipenem. All the three isolates exhibited a higher MIC for imipenem (64-128 µg/mL) compared to meropenem (16-64 µg/mL) [ Figure 1 ]. Inactivating mutation and decreased expression of OprD contribute mainly to imipenem resistance, whereas additional mechanisms, such as overexpresssion of MexAB-OprM efflux pump or AmpC β-lactamases are needed for resistance to meropenem. [13] The findings clearly indicate that inactivating mutation in OprD significantly confers resistance to imipenem but a lesser extent to meropenem.
This study demonstrated that, besides carbapenemase-mediated resistance, alteration in outer membrane porin, OprD can significantly augment imipenem resistance in nosocomial isolates of P. aeruginosa in hospital settings. Although their detection requires sophisticated equipment and trained human resource, information about this intrinsic mechanism may aid in selection of appropriate carbapenem for the treatment of P. aeruginosa and their management as well.
